Glenmark Pharma Gets Orphan Drug Designation For GBR 1342

The US Food and Drug Administration has granted Orphan Drug Designation to its bispecific antibody candidate GBR 1342 for the treatment of patients with multiple myeloma who have received prior therapies.

Share price of Kaveri Seed Company added more than 2 percent on September 17 as meeting of the board of directors of the company will be held on September 24, 2019, to consider a proposal for buyback of fully paid-up equity shares of the company, quantum & mode of buyback and other matters incidental thereto, as per BSE release.

For more information ✆ +91- 6232578593 or visit www.moneymarketmanthan.com